309 related articles for article (PubMed ID: 15197012)
1. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy.
Iyer R; Wilkinson N; Demmy T; Javle M
Ann Surg Oncol; 2004 Jul; 11(7):665-73. PubMed ID: 15197012
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant therapy of esophageal cancer.
Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
[TBL] [Abstract][Full Text] [Related]
3. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
Shinoda M; Hatooka S; Mori S; Mitsudomi T
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemoradiation for the treatment of locoregional esophageal cancer: the standard of care?
Schneider BJ; Urba SG
Semin Radiat Oncol; 2007 Jan; 17(1):45-52. PubMed ID: 17185197
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
6. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
7. Esophageal cancer: outcomes of surgery, neoadjuvant chemotherapy, and three-dimension conformal radiotherapy.
Fréchette E; Buck DA; Kaplan BJ; Chung TD; Shaw JE; Kachnic LA; Neifeld JP
J Surg Oncol; 2004 Aug; 87(2):68-74. PubMed ID: 15282698
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma.
Mooney MM
J Surg Oncol; 2005 Dec; 92(3):230-8. PubMed ID: 16299790
[TBL] [Abstract][Full Text] [Related]
9. Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer.
Kim C; Monjazeb AM; Suntharalingam M; Giesinger KR; Blackstock AW
Clin Adv Hematol Oncol; 2009 May; 7(5):327-333, 342. PubMed ID: 19521322
[TBL] [Abstract][Full Text] [Related]
10. Preoperative or postoperative therapy for resectable oesophageal cancer: an updated practice guideline.
Malthaner R; Wong RK; Spithoff K;
Clin Oncol (R Coll Radiol); 2010 May; 22(4):250-6. PubMed ID: 20398848
[TBL] [Abstract][Full Text] [Related]
11. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
14. [Problematic results of a randomized study of neoadjuvant radiochemotherapy of operable esophageal carcinoma].
Fietkau R; Kundt G
Strahlenther Onkol; 2001 Jul; 177(7):372-3. PubMed ID: 11505624
[No Abstract] [Full Text] [Related]
15. Cancer of the gastroesophageal junction: combined modality therapy.
Ilson DH
Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
[TBL] [Abstract][Full Text] [Related]
16. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.
Veuillez V; Rougier P; Seitz JF
Best Pract Res Clin Gastroenterol; 2007; 21(6):947-63. PubMed ID: 18070697
[TBL] [Abstract][Full Text] [Related]
17. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.
Ruol A; Portale G; Castoro C; Merigliano S; Cagol M; Cavallin F; Chiarion Sileni V; Corti L; Rampado S; Costantini M; Ancona E
Ann Surg Oncol; 2007 Nov; 14(11):3243-50. PubMed ID: 17713823
[TBL] [Abstract][Full Text] [Related]
18. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Varadhachary G; Ajani JA
Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
[TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant therapy in oesophageal cancer surgery].
Imdahl A
Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant therapy for esophageal cancer: surgical considerations.
Piraino A; Vita ML; Tessitore A; Cusumano G; Congedo MT; Margaritora S; Porziella V; Meacci E; Cesario A; Granone P
Rays; 2006; 31(1):37-45. PubMed ID: 16999374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
